Franklin Resources
VTGN icon

Franklin Resources’s VistaGen Therapeutics VTGN Stock Holding History

Franklin Resources’s Portfolio VTGN Stock Details VTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-303,218
Closed -$1.38M – 2387
2022
Q3 		$1.38M Sell
303,218
-11,747
-4% -$116K ﹤0.01% 1443
2022
Q2 		$8.31M Sell
314,965
-16,386
-5% -$579K ﹤0.01% 992
2022
Q1 		$12.3M Sell
331,351
-5,916
-2% -$258K ﹤0.01% 961
2021
Q4 		$19.7M Sell
337,267
-14
-0% -$911 0.01% 893
2021
Q3 		$27.7M Buy
337,281
+5,926
+2% +$515K 0.01% 816
2021
Q2 		$31.3M Sell
331,355
-30,843
-9% -$2.29M 0.01% 765
2021
Q1 		$23.1M Buy
362,198
+154,185
+74% +$10.3M 0.01% 805
2020
Q4 		$12.1M Buy
+208,013
New +$5.31M 0.01% 922

Other funds holding VTGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Franklin Resources's VTGN Position: Q4 2022 in Review

Franklin Resources sold out of VistaGen Therapeutics (VTGN) in Q4 2022, closing a stake of 303,218 shares — an estimated $1.38M sold.

Franklin Resources first reported a position in VTGN in Q4 2020 and held it in 8 quarters. The position peaked at $31.3M in Q2 2021. 85 funds tracked by Wall St. Rank hold VTGN as of Q4 2022.

  • Franklin Resources reported no remaining VistaGen Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Franklin Resources sold 303,218 VistaGen Therapeutics shares in Q4 2022, an estimated $1.38M.
  • Franklin Resources first reported a position in VistaGen Therapeutics in Q4 2020 and held it in 8 quarters.
  • Franklin Resources's VistaGen Therapeutics position peaked at $31.3M in Q2 2021.
  • 85 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q4 2022.

Based on Franklin Resources's 13F filing for Q4 2022, filed 10 Feb 2023.